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ABSTRACT
Background: Chronic systemic hypoxia is severe environmental stress for the heart and
might lead to the development of heart failure. Apelin is an endogenous peptide that has been
shown to have various beneficial effects on cardiac function. Apelin appears to have a role to
play in the ventricular dysfunction and maintaining the performance of the heart.
Objectives: In the present study we want to investigate the adaptive response of heart tissue
to chronic systemic hypoxia and the correlation with apelin expression and oxidative stress in
rat.
Methods: An experimental study was performed using 28 Sprague-Dawley male rats, 8
weeks of age. Rats were divided into 7 groups 4 each, namely control group; normoxia (O2
atmosphere) and the treatment group of hypoxia (8% O2) for 6 hours; 1;3;5;7 and 14 days
respectively. Body weight and heart weight were measured at each treatment. Ventricular
thickness was measured by caliper, Apelin mRNA was measured using real-time qRT-PCR
with Livak formula and malondialdehyde (MDA) level was used to assess oxidative stress
due to cardiac tissue hypoxia.
Results: Macroscopic exams showed hypertrophy at day 7th. The relative expression of
Apelin mRNA in hypoxic heart is decreased at the beginning and then increased, starting
from day-7 to day-14. The MDA levels were significantly increased from day-7 and were
strongly correlated with relative expression Apelin.
Conclusion: It is concluded that the increase of Apelin expression is related to oxidative
stress in heart tissue of rats during chronic systemic hypoxia.
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INTRODUCTION
Hypoxia is a pathological condition
that characterized by an insufficiency of
oxygen supply to fulfill cellular demand.
The level of hypoxic injury in the
cardiovascular system depends on the
hypoxic intensity, the hypoxic stimuli
duration and the cardiac tolerance to
oxygen shortage.[1] The cardiac important
responses to oxidative stress associated
with hypoxia include pathological
hypertrophy and ventricular remodeling.
Cardiac hypertrophy is a maladaptive
precursor to heart failure (HF).[2]
Cardiomyocyte hypertrophy is induced by
a variety of factors such as mechanical
load,[3] neurohumoral factors,[4] and
pathological mechanisms. Cardiac
hypertrophy represents a typical feature of
various cardiomyopathies including
ischemic heart disease and arterial
hypertension.[5] The hypertrophic
responses include changes in the quality
and quantity of various factors, such as cell
size, gene expression, protein synthesis,
and sarcomere organization.[6]
Heart failure is a global problem
with an estimated prevalence of 38 million
people worldwide, and a number that
increases with aging population. Heart
failure is a deadly and costly disease with a
progressive syndrome, characterized by
high mortality, frequent hospitalization,
and a decrease in quality of life resulting
from the inability of the heart to maintain
sufficient cardiac output to meet tissue
needs.[7] Current treatments mainly slow
the development of this syndrome, and
there is a need to develop new preventive
and reparative therapies. For this case, we
feel the need to search for new biomarkers
to complement existing biomarkers using
animal models. The study of HF requiring
animal models that can live where chronic
changes in the structure and function of
myocardial can evolve and progression of
HF and left ventricular dysfunction (LV)
can be quantified.
In this study, the conditions of
oxidative stress in rats were carried out by
normobaric chronic systemic hypoxia,
with the aim of developing an
experimental model of HF.[8] One of the
responses to cardiac stress is an increase in
the expression of various peptides that help
the heart compensate for stress. Adipose
tissue can regulate cardiomyocyte
hypertrophy by issuing various bioactive
factors, through reactive oxygen species
(ROS). The excessive ROS generation in
cardiomyocytes has been shown to
mediate the hypertrophic response to
stretch or other hypertrophic stimuli, such
as angiotensin II, endothelin-1, tumor
necrosis factor- (TNF-).[9,10]
During hypoxia, ROS formation
increases and causes oxidative stress
conditions that play an important role in
the development of left ventricular
hypertrophy and HF.[9-11] If ROS
formation exceeds antioxidant capacity,
ROS produced in ischemic myocardium
can directly cause cell death by damaging
cell membrane lipids, protein,
carbohydrates, and DNA, which leads to
qualitative and quantitative changes in the
myocardium that causes HF.[12,13]
Reaction of ROS with lipid membrane,
rich in polyunsaturated fatty acids will
cause lipid peroxidation. Lipid
peroxidation, which initiated with the
presence of hydroxy radicals which results
in the production of malondialdehyde
(MDA), directly produces oxidative stress.
Thus MDA can be measured by
thiobarbituric acid test (TBARS test).[14]
Apelin is a new adipocytokine,
initially isolated from bovine stomach
tissue extracts by Tatemoto in 1998.[15]
The apelin precursor is translated as a
ISSN : 2654-6108 ; eISSN : 2654-3222 ActaBioIna, Vol 1, No 2 (2018)
70
77–amino acid preproapelin and the apelin
propeptide has many potential proteolytic
cleavage sites forming apelin-36, apelin-19,
apelin-17, apelin-16 apelin-13, apelin-12
and also the pyroglutamate (Pyr1)
apelin-13 subtypes.[15-17] Apelin is a
newly endogenous peptide that is a ligand
for the apelin receptor, which was
described as an orphan G-protein-coupled
receptor (GPCR, APJ).[15-18] All apelin
isoforms may function through the unique
APLNR, their tissue specificity, binding
affinity to APLNR and efficacy in APLNR
recycling may lead to differential functions
of isoforms. It has been shown that apelin
signaling pathways are widely represented
in the cardiovascular system and it is an
important regulator of cardiac function.[19]
Apelin and its receptor APJ are expressed
in several tissues (stomach, heart, lung,
skeletal muscle, etc.) and in the brain,
including the hypothalamus.[20] The
apelin is expressed in the endothelium via
paracrine and endocrine signaling to
activate APJ on myocardial cells,
endothelial cells, and some smooth muscle
cells.[16-21] Apelin has a functional role
in cardiovascular development and may
also participate in cardiovascular
pathological processes.[22-24] In
preclinical models, apelin causes nitric
oxide-dependent vasodilatation and
increases cardiac contractility in rats with
normal and failing hearts.[15,25] Foldes et
al. showed that in human HF Apelin
expression levels were higher than those of
normal tissue, and suggested that apelin
might be involved in the pathophysiology
of human HF.[26] Acute Apelin infusion
increases cardiac output and lowers blood
pressure and peripheral vascular resistance
in patients with HF.[27] Foussal et al.
reported that administration of exogenous
apelin can maintain heart function through
reduced oxidative stress and increase
catalase activity. This suggests that apelin
is a powerful regulator of cardiomyocyte
antioxidant defense against oxidative stress
in hypertrophic myocardial remodeling.[13]
Tatemoto et al. have described a
novel adipokine, produced and secreted by
human and mouse adipocytes, apelin,15
and reported that reactive oxygen species
(ROS) and oxidative stress may increase
the apelin levels.[28,29] The aim of this
study is to analyze the adaptive response
of heart tissue during chronic systemic
hypoxia by investigating the relative
expression of Apelin gene in rat and its
relation with oxidative stress caused by
hypoxia.
MATERIAL AND METHODS
Animal
All procedures were approved by
the Ethical Research Committee FMUI No
354/UN.2F1/ETIK/2015 This study was an
in vivo experimental study, using 28 male
healthy Sprague-Dawley rats weighing
200–250 g. Rats were allowed to access
food and water ad libitum. The animals
were adapted for at least 7 days before
experiments. After a period of adaptation,
the rats were divided into 7 groups
randomly. Group 1 (Normoxia) was
control group within atmospheric air. Six
other groups (Hypoxia: H1-H6), were the
treatment groups, exposed to hypoxia (8%
O2, 92% N2) for 6 hours; 1; 3; 5; 7 and 14
days respectively. All groups were
sacrificed at respected time by mean of
decapitation after ketamine anesthesia. The
thoracic cavity was opened and the heart
was quickly excised from the aortic root.
Heart tissues were weighed and cut
transversely in the subangular region,
below the atrial-ventricular junction in two
parts.[30] The lower part of the heart is
measured by the thickness of the
ventricular wall in the thickest part using
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caliper (precision 0.01 mm) and then heart
tissue placed into microtube frozen
immediately and stored at -80ºC for
analysis of Apelin expressions and MDA
content.
Quantitative real-time RT-PCR
Total RNA was isolated from 25
mg of heart tissue using the Total RNA
Mini Kit, Tissue (Geneaid) according to
the manufacturer’s instructions. Tissue
samples were homogenized in a
microcentrifuge tube using micropestle.
After washing with absolute ethanol, the
final RNA was elected in 50 μl of RNase-
free water. The purity and concentration of
RNA were verified by optical density (OD)
absorption ratio OD260 nm/OD280 nm
between 1.8 and 2.0 using Varioskan
(Thermo Fisher).
Table 1. Primer sequences used by real-time
quantitative RT-PCR
Gene Primer sequences
Apelin Left: 5’-
GTGAAGCCCAGAACTTCGAG-
3’
Right: 5’-
CAGCGATAACAGGTGCAAGA-
3’
18srRNA Left: 5’-
CGCGGTTCTATTTTGTTGGT-3’
Right:5’-
AGTCGGCATCGTTTATGGTC-3’
The homogeneous cDNA was
generated by the reverse transcription of
RNA samples using the AccuPower®
CycleScript RT PreMix (dN12) (Bioneer)
Thermocycler. Real-time PCR was
performed using a detector (Exicycler) and
then subjected to PCR with SYBR Green I
dye in real-time monitoring as the detected
PCR products. The PCR solution
contained specific left primer and right
primer (1 μL each), 5 μl cDNA template,
and adjust by DEPC-distilled water to a
final volume of 20 μL. The PCR primers
designed with Primer3 based on GeneBank
were depicted in Table 1. The reaction
conditions for amplifying DNA were 95
°C for 10 min, followed by 40 cycles of 95
°C for 15s, 61 °C for 30 s, and 72 °C for
30 s. The mRNA expression was
normalized to the expression level of 18s
rRNA and was calculated using the
following equation: Fold change = 2-ΔΔCt
Assessment of oxidative stress by
TBARS estimation
To assess the oxidative damage,
MDA level (a marker of lipid peroxidation)
was measured by reaction with
thiobarbituric acid (TBA) methods as
described Wills. MDA and TBA react to
produce a pink pigment with maximum
absorption at 532 nm. 400 µL of
homogenate was added 200 µL of
trichloroacetic acid (TCA) 20%, then
centrifuged. The supernatant was added
400 µL of a solution of TBA. Furthermore,
it was incubated in a water bath for 10
minutes at a temperature of 80-100oC, then
cooled to room temperature. The
absorbance was measured against a
reference blank at 532 nm by
spectrophotometer Genesys 10 UV
scanning thermoscientific. 1,1,3,3-
tetramethoxypropane (Sigma Chemicals,
USA) were used as a standard. The levels
of MDA in heart tissue were expressed as
nmol/mL.
Statistical Analysis
All data were presented as means ±
SEM (n = 4 per group) and analyzed using
GraphPad software (Version 6, for
windows). A one-way analysis of variance
(ANOVA) was used to detect statistical
differences between groups. A post hoc
test (LSD) was performed to determine
differences between groups. Significant
differences were considered at p < 0.05.
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RESULTS
Table 1 shows the results of blood
gas analysis and hematology. The changes
in various parameters as induced by
hypoxia, which was expressed as mean ±
SEM (standard error of the mean). Table 1
shows the pO2, pCO2, arterial O2 saturation,
and HCO3- decreased gradually in line
with the duration of treatment of hypoxia,
while blood pH decreased at the end of
exposure. On the other hand, hypoxia led
to an increase in hemoglobin, hematocrit
and red blood cells (RBC). The increase in
all three parameters will continue until the
end of the treatment and the concentration
or amount to be very high.
Figure 1 shows macroscopic
features of the normal and chronic
systemic hypoxia cross-section of rats
ventricular after hypoxia of 6 hours 3, 5,7
and 14 days respectively. The ventricular
wall thickness was significantly increased
at right ventricular on 7 days hypoxia and
left ventricular on 5 days hypoxia, which
indicated an occurrence of ventricular
hypertrophy induced hypoxia.
Table 2 shows morphometric
evaluation of the normal and chronic
systemic hypoxia of rats heart ventricular
in hypoxia 6 hours, 1 day, 3 days, 5 days,
7 days and 14 days. A significant increase
was observed in both the right ventricular
after 7-days of hypoxia and left ventricular
after 5-days of hypoxia. The ratio of
ventricular thickness (hypertrophy index)
of the right ventricular wall was greater
than the left ventricular, as seen after 5
days of hypoxia.
Table 1. Blood gases and hematology Values
Parameter Normoxia
H y p o x i a
6 hours 1 day 3 days 5 days 7 days 14 days
pO2 (mmHg) 95.9 ± 2.0 85.1 ± 0.9 64.2 ±
3.5
59.0 ±
2.6*
53.7 ±
0.9*
44.4 ±
2.1*
35.1 ±
1.9*
pCO2 (mmHg) 40.4 ± 1.3 38.3 ± 0.5 36.2 ±
1.3
33.3 ±
1.0*
31.3 ±
0.8*
29.2 ±
1.6*
23.7 ±
1.1*
Ph 7.40 ±
0.01
7.40 ±
0.01
7.39 ±
0.00
7.39 ±
0.0
7.38 ± 0.00 7.38 ±
0.01*
7.38 ± 0.01*
HCO3- (mmol/L) 24.3 ± 1.3 23.2 ± 0.7 22.1 ±
1.1
20.4 ±
0.9
19.1 ± 0.2 17.9 ±
0.5*
14.9 ±
0.6*
O2 Saturation
(%)
94.1 ± 1.5 80.8 ± 1.0 67.5 ±
3.1
60.7 ±
2.7*
58.0 ±
0.7*
55.3 ±
2.1*
52.1 ±
4.2*
Hemoglobin
(g/L)
12.01 ± 0.06 12.03±0.08 13.1 ±
0.1
15.01± 0.2* 16.09± 0.1* 17.2 ±
0.2*
19.9 ±
0.2*
Hematocrit (%) 45.3 ± 1.2 46.5 ± 0.4 47.7 ±
1.7
52.5 ±
1.8*
55.4 ±
0.4*
58.3 ±
1.1*
63.2 ±
1.2*
RBC (ml/1000) 6.8 ± 0.1 6.9 ± 0.0 7.1 ± 0.1 8.0 ± 0.0* 8.3 ±
0.1*
8.5 ± 0.2* 9.7 ± 0.2*
Mean values ± SE, * (Significant difference versus normoxia P<0.05,
pO2, pCO2, O2 saturation and HCO3- fall dramatically, this means that the treatment provided is causing
systemic hypoxia. In Advance hypoxia created severe metabolic acidosis (decrease in pH and HCO3-) with the
compensation for severe respiratory alkalosis (pCO2 decreased).
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Table 2. Evaluation of cardiac morphometric
Parameter Normoxia
Hypoxia
6 hours 1 day 3 days 5 days 7 days 14 days
Right ventricular
thickness (mm)
1.36±0.02 1.38±0.06 1.4±0.05 1.43±0.03 1.61±0.02 1.74±0.03* 1.9±0.09*
Right ventricular
hypertophy (%)
0.92% 2.75% 4.59% 18.35% 27.52% 39.45%
Left ventricular
thickness (mm)
2.23±0.03 2.28±0.03 2.30±0.02 2.34±0.02 2.4±0.02* 2.61±0.06* 2.79±0.06*
Left ventricular
hypertophy (%)
2.25% 3.37% 5.06% 7.87% 17.42% 25.28%
Mean Value ± SEM, * significant difference versus normoxia (p <0.05)
Index Hypertrophy (%) = ((Ventricular Thickness Hypoxia - Ventricular Thickness normoxia) / Ventricular
Thickness normoxia) x 100%
A B C
D E F
Figure 1. The macroscopic features of the normal and
chronic systemic hypoxia cross-section of rats heart
ventricular. Transverse sections of the hearts. A.
Normoxia, B. 6 hour hypoxia, C. 3 day hypoxia, D.
5 days hypoxia, E. 7 days hypoxia, and F. 14 days
hypoxia. The left ventricular and right ventricular
wall thickness increases in proportion with the
duration of hypoxia treatment.
Figure 2. The expression of mRNA Apelin in the heart
tissue. There were significant differences between
normoxia and the hypoxic groups 7th and 14th days.
Figure 3. MDA levels in Heart Tissue. There were
significant differences between normoxia and the
hypoxic groups 7th and 14th days.
Figure 4. Correlation of MDA levels and Apelin
relative expression in heart tissue of rat-induced by
systemic hypoxia. The level of MDA and relative
expression Apelin is strongly correlated and
significant (r = 0.667; p = 0.001).
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Figure 2 shows relative expression
of apelin as a result of chronic hypoxia
induction, in mean±SE. Product of real-
time RT-PCR was detected as fluorescence
absorbance of SYBR Green. Threshold of
fluorescence curve was set-up to achieve
the optimum efficiency of expression. The
relative expression of Apelin mRNA in
heart hypoxic was decreased at the
beginning and dramatically increased with
the duration of treatment, starting from 7-
days until the end of the treatment period.
Total RNA was extracted from the heart,
and measured by UV light absorption
wavelength of 260 nm.
MDA, a biomarker of cardiac
oxidative injury, is a product of lipid
peroxidation that can be produced by a
variety of oxidative damages. As shown in
Figure 3, the hypoxia significantly
increased MDA levels at days 7 and 14 (P
< 0.001) in comparison with normoxia
group. The increase of MDA occurred
from the beginning (h 6 hours) until the
end of the treatment. Figure 4 showed that
the increase of Apelin expression is related
to oxidative damage in heart tissue of rats
during chronic systemic hypoxia.
DISCUSSION
The experimental study conducted
in rats which were conditioned to hypoxia
for 14 days using 8% O2 and 92% N2. All
parameters such as blood gases pO2, pCO2,
O2 saturation, and HCO3- fall dramatically,
this means that the treatment provided is
causing systemic hypoxia. In Advance
hypoxia created severe metabolic acidosis
(decrease in pH and HCO3-) as the
compensation for the shortness of breath
due to lack of O2 breathing accelerated and
pCO2 decreased causing respiratory
alkalosis. Witt et al.[31] reported that the
striking decline from the same parameters
has occurred since the first hours of
exposure to hypoxia. Comparable results
were also reported by other
researchers.[1,32] The increased in
hemoglobin, hematocrit and RBC occurred
as compensation for the decrease of pO2
level in the network, so that through the
increase in all parameters, improved O2
transport. However, this causes an increase
in blood viscosity, making the heart work
harder.
Systemic chronic hypoxia causes
an increase of ventricular wall thickness.
The left and right ventricular wall
thickness were increased in proportion
with the duration of treatment. Similar
changes in cardiac morphometry were also
found by Ferdinal et al.[32] In physiologic
levels, ROS act as signaling molecules in
several cellular functions; on the other
hand, in pathologic conditions
overproduction of ROS have deleterious
effects by damages to the several cellular
components.[33] An important mechanism
that can explain the occurrence of
ventricular hypertrophy as a result of
hypoxia is oxidative stress as a result of
increased ROS production that leads to cell
death, either through the mechanism of
apoptosis or by necrosis or autophagy.
Furthermore, hypoxia causes fibrosis of
the vascular endothelium, either as a direct
effect or by stimulating the secretion of
Angiotensin II are derived from the
sympathetic nervous system and resulting
in heart.[8]
Apelin is a peptide ligand of the
APJ receptor implicated in cardiovascular
diseases. Apelin has many functions such
as a positive inotropic, vasodilator and
diuretic. The apelin and its receptor can be
found in the adipose tissue, with higher
concentrations in the lung and
cardiovascular system.[34] This study
reports that apelin myocardial expression
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and secretion are activated by hypoxia. We
observe an early upregulation of the rat
apelin gene expression under hypoxia (8%
O2) in the heart cells. Rokainen et al.[28]
said the hypoxia increases the apelin
expression in cultured cardiomyocytes.
To determine hypoxia-induced
regulation of apelin, we measured mRNA
expression after treatment of the rats with
hypoxia (8% O2, 92% N2).for different
time periods. Total RNA was isolated from
the heart of a rat exposed to normoxic and
hypoxic conditions (8% O2). After 7 days,
the apelin mRNA was significantly
increased in the heart of the rat exposed to
hypoxia. The expression of Apelin mRNA
in heart tissue is shown in Figure 2.
Hypoxia and various other stimuli induce
HIF-1α signaling cascade, and then
transcriptionally activate multiple
genes.[35]
It has been reported that apelin is
present in human plasma and the
myocardium.[16,28] In chronic HF due to
ischemic heart disease or dilated
cardiomyopathy there is an increase the
apelin mRNA levels and apelin plasma
levels are reported to increase in the early
stage of left ventricular dysfunction.[25,36]
Ronkainen et al. said the most presumable
candidate for the regulation of apelin gene
expression would be hypoxia-inducible
factor-1 (HIF-1).[28] HIF-1 is activated in
hypoxia due to the prevention of oxygen-
dependent HIF prolyl-4-hydroxylase (HIF-
P4H)-mediated proline hydroxylation,
which in normoxia targets the HIF-1
subunit for ubiquitination and proteasomal
degradation.
Hypoxia leads to increased
formation of free radicals. MDA is
produced in the process of lipid
peroxidation by ROS, thus that the
measurement of concentration, is used as a
biochemical marker of oxidative stress. In
hypoxia, ROS production in the
respiratory chain increased particularly
superoxide anion, as a result of leakage of
electrons, resulting in a partial reduction of
oxygen. In this study, the treatment of
hypoxia comparable to the increased
concentration of MDA. The high
concentration of unsaturated fatty acids in
cell membranes makes cell membranes the
main target of free radicals that are formed
lipid peroxide with solving the main
results in the form of MDA. We
demonstrated that the level of MDA in
heart tissue had increased since day-1 of
hypoxia. The MDA levels increased with
the length of exposure to hypoxia and
reach the maximum level at the day-14
with a significant increase on day-7 and
day-14 of hypoxia The increased level of
MDA in heart tissue also proved by Folden
et al.[37] which found that oxidative stress
caused to an increase in MDA level.
Increased ROS formation from
mitochondria will trigger the redox
signaling cascade. ROS will activate
signaling pathways and in turn activate
transcription factor and expression of
target gene.[2,38,39]
Correlation between MDA of rat
heart with relative expression of mRNA
Apelin of heart tissue got result of
correlation coefficient equal to 0,667
which showed a strong positive correlation.
This shows that Apelin is expressed under
hypoxia/oxidative stress. This is consistent
with the increase in MDA concentrations
were positively correlated strongly to
increase the Apelin relative expression.
CONCLUSION
We created an experimental rat
heart damage model with chronic systemic
hypoxia. This damage is supported by a
significant increase in the relative
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expression of Apelin mRNA in chronic
systemic hypoxia starting from the 7th day.
This shows structural damage due to
pressure overload in the ventricular cavity
and the ventricular wall stretching
resulting in increased ventricular wall
thickness. Induction of chronic systemic
hypoxia causes an increase in formation of
MDA in rat heart tissue because the
formation of ROS increases during
hypoxia. This study shows that Apelin
mRNA levels can be candidates as
biochemical markers of heart damage.
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